Pharmaceutical development start-up Xaira Therapeutics received a $1 billion capital commitment this week, with investment from several Silicon Valley giants such as Sequoia Capital and Lightspeed Venture Partners.。The company hopes to use artificial intelligence (AI) models to discover new drugs under the management of Marc Tessier-Lavigne, the former president of Stanford University who resigned last year.。
US Stock 7x24
2024-04-24 08:06:37
2.50W
Pharmaceutical development start-up Xaira Therapeutics received a $1 billion capital commitment this week, with investment from several Silicon Valley giants such as Sequoia Capital and Lightspeed Venture Partners.。
The company hopes to use artificial intelligence (AI) models to discover new drugs under the management of Marc Tessier-Lavigne, the former president of Stanford University who resigned last year.。
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.
